The vaccine produced in Russia from the coronavirus “satellite V” was the second in terms of efficiency in Hungary after the MODERNA preparation. This became known from the results of a study published in Clinical Microbiology and Infection magazine.
Scientists checked the effectiveness of vaccinations in 3.7 million citizens of Hungary over 16 years. Most often, the Hungarians are given to the drug from PFizer-Biontech (1.5 million people), in second place in popularity – Chinese SINOPHARM (895 thousand), on the third – “satellite V” (820 thousand), closes the list of Astrazeneca (304 thousand) and Moderna (222 thousand).
As a result, the greatest effectiveness against Coronavirus infection showed the MODERNA preparation – 88.7 percent, in second place “satellite V” from 85.7 percent. The Pfizer-Biontech vaccine has shown 83.3 percent of efficiency, Astrazeneca is 71.5 percent, Sinopharm is 68.7 percent. At the same time, the “satellite V” best protects people from fatal outcome as a result of the disease COVID-19.
previously became known that Argentina approved the Russian Satellite Light vaccine as an independent preparation and booster vaccine. According to the Russian Foundation for direct investment, the Vaccination “Satellite V” in Argentina played a key role in the struggle against incidence of coronavirus and mortality from COVID-19.